LXRX Q2 2022 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35,000-85.0% YoY

Gross Profit

$35,000100.0% margin

Operating Income

-$24M-68591.4% margin

Net Income

-$25M-70248.6% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-5.4%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$112M

Total Liabilities

$41M

Stockholders' Equity

$71M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35,000	$234,000	-85.0%
Gross Profit	$35,000	-$10M	+100.3%
Operating Income	-$24M	-$18M	-33.7%
Net Income	-$25M	-$18M	-36.1%